Tumors During Surgery Articles & Analysis
17 news found
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the execution of an exclusive licensing option for LuCaFab (now ITM-31), a novel Targeted Radionuclide Therapy candidate for the treatment of malignant glioblastoma. ITM-31 is a carbonic anhydrase XII (CA XII)-specific antibody Fab fragment developed by Helmholtz Munich and coupled with ITM's ...
Diffusion Pharmaceuticals Inc.(NASDAQ: DFFN) (“Diffusion” or the “Company”), a biopharmaceutical company developing novel therapies that enhance the body’s ability to deliver oxygen to areas where it is needed most, today announced a significant expansion of its Scientific Advisory Board (SAB) to include five prominent radiation and medical oncologists to help guide ...
ByCervoMed
Combining engineering and medicine can lead to world-leading tools like the Raman spectroscopy, which can help to distinguish cancer cells from healthy cells; for example, in brain tumour surgery.ISTOCKPHOTO / GETTY IMAGES One of the biggest challenges in brain tumour surgery is making sure that all cancer cells are removed. “If you leave a few cancer cells behind, the cancer will come ...
Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT) announced that the National Cancer Institute (NCI) has resumed enrolling patients into their pharmacologic study of the ability of Lixte’s lead compound, LB-100, to enter the brain and penetrate recurrent, malignant brain tumors, in patients where surgical removal of their cancer is indicated. After enrolling two patients in the study, ...
She is the Co-Director of the UCLA Brain Tumor Center, and Principal Investigator and Director of the NCI-designated UCLA Brain Tumor SPORE (Specialized Program of Research Excellence). ...
SANTA CLARA, Calif., Sept. 28, 2021 /PRNewswire/ -- Invenio Imaging announced today that it has obtained the CE Mark for the NIO Laser Imaging System according to the In Vitro Diagnostic Directive (IVDD). This enables commercialization of this novel imaging system for intraoperative histology in the European market. The NIO Laser Imaging System uses Stimulated Raman Histology to ...
” About Tumor Treating Fields Tumor Treating Fields, or TTFields, are electric fields that disrupt cancer cell division. ...
This novel non-thermal process (24-27o C) has been developed for treating solid cancerous tumors. After the surgeon removes the cancerous tumor during surgery, CHCP is subsequently sprayed at the surgical margins to target any remaining cancerous tissue or cells, thus reducing the chances of cancer recurrence. ...
A University Hospitals Cleveland Medical Center neurosurgeon is among the first in the region to begin offering GammaTile® Therapy, a new approach to treating brain tumors. GammaTile Therapy is an FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) that is designed to delay tumor regrowth for patients with brain tumors while protecting healthy brain tissue. University Hospitals Seidman ...
A University Hospitals Cleveland Medical Center neurosurgeon is among the first in the region to begin offering GammaTile® Therapy, a new approach to treating brain tumors. GammaTile Therapy is an FDA-cleared, Surgically Targeted Radiation Therapy (STaRT) that is designed to delay tumor regrowth for patients with brain tumors while protecting healthy brain tissue. University Hospitals Seidman ...
Head and neck cancer surgery presents a number of unique challenges, not only for the surgeon but for the radiation oncologist who will subsequently treat those patients. Great care with an emphasis on precision must be taken to ensure that critical structures and tissues avoid collateral damage when possible. However, given the surgical site often lies in soft tissue, exact identification of the ...
A new imaging technique and artificial intelligence (AI) are poised to significantly advance what neurosurgeons can do to help patients with brain tumors while they’re on the operating room table. Brain tumor surgery is, traditionally, a high-stakes and time-critical procedure. ...
To help neurosurgeons diagnose brain tumors more efficiently, researchers from the University of Michigan developed a deep learning-based imaging technique that can reduce the tumor diagnosis process during surgery from 30-40 minutes to less than three minutes. First unveiled in 2017, the technique called stimulated Rama ...
Dr. Rabia Z. Bhatti with the AMITA Resurrection Medical Center has always had a strong interest in the art of surgery. “I actually love the way that patients recover,” she explained. “There’s a gratification behind treating patients and watching them get better. And after practicing general surgery for 15 years, I realized I could provide even better care to my patients by ...
SurgiMab and Quest Medical Imaging, a leader in the market for multispectral cameras, announced today that they have entered into a collaboration agreement for the upcoming Phase III clinical trial of Surgimab’s SGM-101 in fluorescent guided colorectal cancer surgery. Under the terms of the agreement, Quest Medical Imaging has received an undisclosed lump sum payment to ...
BySurgiMab
On Sunday, 3rd July, Mike Callaghan – Head of Business Development at GPT Waste Management Ltd completed the Windermere Triathlon in a bid to raise funds for The Joshua Wilson Brain Tumour Charity. The Windermere Triathlon is in no way for the faint hearted. It is a challenge only undertaken by those strong enough, and brave enough to believe they can reach the finish line. Starting with ...
Edinburgh Molecular Imaging Ltd. (EM Imaging) has signed an exclusive global license for a novel optical imaging agent that could improve the detection of early-stage colorectal (bowel) cancer. EM Imaging, a company which develops and commercialises novel optical imaging agents, recently signed the licensing agreement with GE Healthcare Ltd. and Dyax Inc. EM Imaging will now complete the ...